Table 1.
Characteristics of the study population
| Factor | Emergent LDLT (n = 16) | Elective LDLT (n = 31) | P value |
|---|---|---|---|
| Preoperative factors | |||
| Females (%) | 9 (56.2) | 14 (45.1) | 0.47 |
| Age (years) | 42.3 ± 14.4 | 51.3 ± 8.0 | 0.03 |
| MELD score | 27.4 ± 7.6 | 15.1 ± 6.6 | 0.001 |
| ABO incompatibility | 2 (12.5) | 8 (25.8) | 0.29 |
| Tracheal intubation (performed) | 7 (43.7) | 0 (0) | 0.001 |
| PaO2/FiO2 ratio | 335.2 ± 110.2 | 405.6 ± 73.7 | 0.03 |
| HDF | 13 (81.2) | 0 (0) | 0.001 |
| Steroid (1 month) | 11 (68.7) | 5 (16.1) | 0.001 |
| Lymphocyte count | 806 ± 856.3 | 960 ± 533.5 | 0.02 |
| Intraoperative factors | |||
| Duration of operation (min) | 1085.4 ± 807.6 | 929.2 ± 164.3 | 0.45 |
| e-Blood loss (ml) | 6375.0 ± 8048.7 | 6257.1 ± 4926.8 | 0.95 |
| Warm ischemic time (min) | 61.3 ± 18.4 | 64.7 ± 18.6 | 0.55 |
| Cold ischemic time (min) | 137.4 ± 71.8 | 185.6 ± 96.2 | 0.06 |
| Splenectomy (performed) | 5 (31.2) | 15 (48.3) | 0.26 |
| Right lobe graft | 11 (68.7) | 22 (70.9) | 0.87 |
| Postoperative factors | |||
| Duration of admission (days) | 93.6 ± 53.1 | 57.3 ± 38.4 | 0.02 |
Data are presented as number of patients (percentages in parentheses) or mean ± SD
LDLT living donor liver transplantation, MELD model for end-stage liver disease, PaO 2 /FiO 2 ratio ratio between arterial oxygen tension and fractional inspired oxygen, HDF hemodiafiltration, e-Blood loss estimated blood loss